CFB
CLB icon

Cullen/Frost Bankers’s Core Laboratories CLB Stock Holding History

Cullen/Frost Bankers’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.99K Hold
600
– – ﹤0.01% 1190
2026
Q1 		$10.1K Hold
600
– – ﹤0.01% 1104
2025
Q4 		$9.62K Buy
+600
New +$8.93K ﹤0.01% 1123
2025
Q1 		– Sell
-56
Closed -$969 – 1316
2024
Q4 		$969 Buy
+56
New +$1.08K ﹤0.01% 1252
2024
Q3 		– Sell
-9
Closed -$183 – 1248
2024
Q2 		$183 Buy
+9
New +$159 ﹤0.01% 1227
2021
Q4 		– Sell
-257
Closed -$7K – 1208
2021
Q3 		$7K Buy
+257
New +$7.82K ﹤0.01% 1088

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Cullen/Frost Bankers's CLB Position: Q2 2026 in Review

Cullen/Frost Bankers held its Core Laboratories (CLB) position steady in Q2 2026 at 600 shares worth $6.99K. The position accounts for ﹤0.01% of the portfolio, ranked #1190.

Cullen/Frost Bankers first reported a position in CLB in Q3 2021 and has held it in 6 quarters since. The position peaked at $10.1K in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Cullen/Frost Bankers held 600 shares of Core Laboratories worth $6.99K as of Q2 2026.
  • Cullen/Frost Bankers left its Core Laboratories share count unchanged in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Cullen/Frost Bankers's portfolio in Q2 2026, its #1190 holding.
  • Cullen/Frost Bankers first reported a position in Core Laboratories in Q3 2021 and has held it in 6 quarters since.
  • Cullen/Frost Bankers's Core Laboratories position peaked at $10.1K in Q1 2026.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.